Blockchain for PHARMA Scientists & Engineers
  • What is Blockchain BioPharma?
    • Blockchain BioPharma: R&D Origins
      • Harvard Business Review: Why Big Pharma Is Betting on Blockchain
    • 2022 DEV OPS ROADMAP
    • WEDNESDAY, MARCH 16,2022 SPRINT 0: DEMO VIDEO
    • PHARMA INDUSTRY SOLUTIONS: The 80/20 Non-Profit Pharma Company
    • Our Calling for a Pharmaceutical Coalition
    • BLOCKCHAIN BIOPHARMA: INVESTMENT GOALS AND CRITERIA DATA
    • $20(M-USD) Is The Important Number - As of Now We Have 200 Million ERC & BEP PHARMA Tokens.
    • DAO Mission & Vison
      • Where Will Pharmaceutical eNFT's Come From?
    • Information Architecture Diagram
      • WARNING! ALT-COINS GLOBALLY TARGETED - NEED FOR DEVSECOPS
    • Blockchain BioPharma GAP Analysis
    • Blockchain BioPharma Tokenomics
      • PROPOSED GLOBAL CENTRAL BANK CBDC INTEGRATIONS
      • INTEGRATION POINTS FOR SWIFT & CBDC's
    • BANKING-GRADE SECURITY: SWIFT CODE INTEGRATION
    • Sales & Revenue Model
      • PRODUCT: Quantum SSO
      • PRODUCT: Metaverse Software Apps
      • PRODUCT: eNFT Marketplace for Medicines (Polygon)
        • TYPES OF ENTERPRISE PHARMA eNFT’s:
      • PRODUCT: Metaverse of PHARMA - Introducing CloudLab (VR/AR)
      • SERVICE: Metaverse Development MSP
        • Blockchain BioPharma: MSP Services Rate Card
      • SERVICE: Private-Label IP Monetization (HyperLedger)
      • SERVICE: ENTERPRISE BLOCKCHAIN SMART CONTRACT GAS-FEES
    • What is the Pharmaceutical Token (Ticker: PHARMA)?
      • Are PHARMA Tokens Regulated?
      • Legal Position on the Pharmaceutical Token
      • Using Ethereum Blockchain for Pharmacogenomics Smart Contracts
    • Where Can You Download The Blockchain BioPharma Desktop Applications?
    • What Industries Do We Target?
    • Are PHARMA Tokens on the Cryptocurrency Exchanges?
    • Who Uses The Blockchain BioPharma Application?
    • Does Blockchain BioPharma Loan Money to Drug Developers?
    • Desktop Software Demo
    • Enterprise Pharma eNFT Example
    • Artificial Intelligence & Machine Learning
    • STATE OF THE METAVERSE UNION - Metaverse Market Research
    • Q2 - 2022: Crowdsale
    • Smart Contract Types
    • Competitive Landscape
      • AGILE: Our Competitive Advantage
  • The Competition Justifies our Business Model
    • COMPETITOR #1: Molecule.to
    • COMPETITOR #2: Pharmalyse Finance
  • Get in Touch With Our Community
  • 100% Regulatory and Compliance Transparency
    • Crypto Accounting 101: Price Water House Coopers Regulatory Compliance Opinion
Powered by GitBook
On this page

Was this helpful?

  1. What is Blockchain BioPharma?

BLOCKCHAIN BIOPHARMA: INVESTMENT GOALS AND CRITERIA DATA

Investment will go toward software development, #Data Collection operations, digital advertising, regulatory and compliance for a global scale, liquidity, and market maker services.

PreviousOur Calling for a Pharmaceutical CoalitionNext$20(M-USD) Is The Important Number - As of Now We Have 200 Million ERC & BEP PHARMA Tokens.

Last updated 3 years ago

Was this helpful?

We have selected #Consensys's MetaMask Institutional Account, and several other high-security / high-quality Crypto Wallets to safely store Pharmaceutical Tokens (Ticker: PHARMA), including cold-storage.

  • TIME-FRAME

    • 3-Months

  • MINIMUM NEEDED FOR COMMERCIAL VIABILITY

    • $25 Million

  • MAXIMUM NEEDED FOR CROWD FUNDING SERIES A, B, C

    • $300 Million

  • $25 MM Seed Round

    • Investors will be granted voting rights in the DAO, powered by transparent Voting Smart Contracts. Collaboration in this early stage is critical, and we seek partners with a vested interest in the success of Blockchain BioPharma's #Mission. We want only high performers.

  • MINIMUM TOKEN PRICING FOR ENTERPRISES:

    • $6.00 - 1 Million PHARMA Tokens Purchased

    • $5.00 - 2 Million PHARMA Tokens Purchased

    • $4.00 - 3 Million PHARMA Tokens Purchased

  • CASH FLOW REQUIREMENTS WITH $20(M) INVESTMENT MINIMUM

    • [$500(k)] = Monthly Startup Burn Data (Platform Development, Advertising / Partnership Development, Survey, Research & Development, and Scrum Team)

    • [$250(k)] = Remaining Regulatory Licensing Costs

    • [$100,000(k)] = Approximate 3rd - Party Data Providers

    • [$50(k) = Auditing and Remittal of Audits via and Smart Contracts $100,000

Software Products & Services

WE DO NOT MAKE INVESTMENT RETURN PROMISES THUS NO PRO-FORMAS. WE ONLY PRESENT EXISTING QUALITATIVE AND QUANTITAVE DATA AVAILABLE

CRYPTO IS A RISKY BUSINESS – LASTLY, VOTERS IN OUR DECENTRALIZED AUTONOMOUS ORGANIZATION WILL INFORM THE BUSINESS, eNFT INVESTMENT, AND MANAGEMENT DECISIONS - TARGET DATE Q2 2022.

REQUIRED READING:

The US Treasure Departments Stablecoin Analysis

o Investor Relations Contact:

Developers@BlockchainBiopharma.com
#Regulatory
#Compliance
Currently, we are working to integrate 26 different global derivative and cryptocurrency trading platforms to list our Pharmaceutical Token (Ticker: PHARMA)